| renal tubular secretion | GO:0097254 | 2 | 0.649 | |
| regulation of secretion | GO:0051046 | 274 | 0.619 | Mouse |
| naphthalene metabolic process | GO:0018931 | 1 | 0.585 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.554 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.516 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.432 | |
| positive regulation of steroid hormone secretion | GO:2000833 | 2 | 0.410 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.409 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.382 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.374 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.353 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.320 | Mouse |
| transmembrane transport | GO:0055085 | 412 | 0.312 | |
| positive regulation of estrogen secretion | GO:2000863 | 1 | 0.290 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.289 | |
| regulation of estrogen secretion | GO:2000861 | 1 | 0.285 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.271 | |
| cation transport | GO:0006812 | 399 | 0.266 | Mouse |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.250 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.246 | |
| diacylglycerol biosynthetic process | GO:0006651 | 2 | 0.242 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.236 | Mouse |
| cofactor metabolic process | GO:0051186 | 80 | 0.236 | |
| circulatory system process | GO:0003013 | 197 | 0.216 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.213 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.211 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.207 | Mouse |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.207 | |
| activation of immune response | GO:0002253 | 138 | 0.198 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.198 | |
| oxidation reduction process | GO:0055114 | 342 | 0.198 | |
| renal system process | GO:0003014 | 48 | 0.191 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.178 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.173 | Mouse |
| hormone secretion | GO:0046879 | 128 | 0.173 | Mouse |
| regulation of hormone secretion | GO:0046883 | 88 | 0.172 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.171 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.163 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.153 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.152 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.147 | Mouse |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.144 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.143 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.142 | |
| regulation of system process | GO:0044057 | 200 | 0.134 | |
| medium chain fatty acid metabolic process | GO:0051791 | 1 | 0.130 | |
| estrogen secretion | GO:0035937 | 1 | 0.124 | |
| innate immune response | GO:0045087 | 157 | 0.124 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.117 | |
| peptide transport | GO:0015833 | 133 | 0.117 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.117 | |
| hormone metabolic process | GO:0042445 | 86 | 0.117 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.116 | |
| drug metabolic process | GO:0017144 | 4 | 0.113 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.111 | |
| response to metal ion | GO:0010038 | 47 | 0.110 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.107 | |
| endocrine process | GO:0050886 | 39 | 0.104 | |
| sterol homeostasis | GO:0055092 | 45 | 0.102 | |
| lipid transport | GO:0006869 | 98 | 0.101 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.096 | |
| respiratory system development | GO:0060541 | 190 | 0.096 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.094 | Mouse |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.093 | |
| anion transport | GO:0006820 | 177 | 0.092 | |
| regulation of macrophage activation | GO:0043030 | 17 | 0.091 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.089 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.088 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.086 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.084 | Mouse |
| lipid homeostasis | GO:0055088 | 63 | 0.082 | |
| renal sodium excretion | GO:0035812 | 3 | 0.082 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.080 | |
| cellular homeostasis | GO:0019725 | 240 | 0.080 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.079 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.078 | |
| regulation of thyroid hormone generation | GO:2000609 | 4 | 0.078 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.078 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.077 | Mouse |
| amide transport | GO:0042886 | 138 | 0.077 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.075 | Human |
| peptide hormone secretion | GO:0030072 | 109 | 0.075 | |
| response to oxygen levels | GO:0070482 | 62 | 0.075 | |
| lipid localization | GO:0010876 | 126 | 0.075 | |
| amine metabolic process | GO:0009308 | 45 | 0.072 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.069 | Mouse |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.069 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.067 | Mouse |
| linoleic acid metabolic process | GO:0043651 | 6 | 0.066 | |
| wound healing | GO:0042060 | 157 | 0.066 | |
| regulation of cell motility | GO:2000145 | 236 | 0.064 | Mouse |
| nk t cell proliferation | GO:0001866 | 2 | 0.063 | |
| immune effector process | GO:0002252 | 321 | 0.062 | Mouse |
| response to peptide | GO:1901652 | 136 | 0.061 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.061 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.060 | Human |
| cell chemotaxis | GO:0060326 | 81 | 0.060 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.059 | |
| response to inorganic substance | GO:0010035 | 96 | 0.059 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.059 | |
| drug catabolic process | GO:0042737 | 2 | 0.058 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.058 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.058 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.058 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.058 | |
| response to nutrient levels | GO:0031667 | 109 | 0.057 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.056 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.056 | |
| tetrapyrrole metabolic process | GO:0033013 | 22 | 0.056 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.056 | |
| cation homeostasis | GO:0055080 | 212 | 0.056 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.054 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.054 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.053 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.053 | Human |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.052 | |
| steroid metabolic process | GO:0008202 | 119 | 0.052 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.051 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.051 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.050 | Mouse |
| lung development | GO:0030324 | 164 | 0.050 | |
| cytokine production | GO:0001816 | 319 | 0.049 | Mouse |
| regulation of tube size | GO:0035150 | 57 | 0.048 | |
| organic anion transport | GO:0015711 | 137 | 0.048 | |
| epithelial cell development | GO:0002064 | 159 | 0.047 | |
| heme metabolic process | GO:0042168 | 16 | 0.046 | |
| long chain fatty acid metabolic process | GO:0001676 | 26 | 0.046 | |
| blastocyst development | GO:0001824 | 80 | 0.046 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.046 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.046 | |
| regulation of brown fat cell proliferation | GO:0070347 | 1 | 0.045 | |
| insulin secretion | GO:0030073 | 89 | 0.045 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.045 | |
| protein processing | GO:0016485 | 163 | 0.045 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.045 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.045 | |
| chromatin modification | GO:0016568 | 187 | 0.044 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.044 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.043 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.042 | |
| arachidonic acid metabolic process | GO:0019369 | 14 | 0.042 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.041 | |
| organic acid transport | GO:0015849 | 101 | 0.041 | |
| sterol metabolic process | GO:0016125 | 58 | 0.041 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.041 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.041 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.041 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.041 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.040 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.040 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.040 | |
| regulation of cell killing | GO:0031341 | 40 | 0.039 | |
| response to peptide hormone | GO:0043434 | 127 | 0.039 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.039 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.039 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.039 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.039 | |
| extracellular structure organization | GO:0043062 | 148 | 0.039 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.038 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.038 | |
| potassium ion transport | GO:0006813 | 52 | 0.038 | |
| humoral immune response | GO:0006959 | 57 | 0.038 | |
| regulation of defense response | GO:0031347 | 233 | 0.038 | Mouse |
| positive regulation of secretion | GO:0051047 | 130 | 0.038 | Mouse |
| cation transmembrane transport | GO:0098655 | 266 | 0.038 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.037 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.037 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.037 | |
| organ or tissue specific immune response | GO:0002251 | 13 | 0.037 | Human |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.037 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.036 | Mouse |
| regulation of systemic arterial blood pressure by atrial natriuretic peptide | GO:0003050 | 2 | 0.036 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.036 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.036 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.035 | |
| tissue homeostasis | GO:0001894 | 115 | 0.035 | Human |
| multicellular organism growth | GO:0035264 | 161 | 0.035 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.035 | |
| regulation of cell activation | GO:0050865 | 289 | 0.035 | Mouse |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.035 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.035 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.035 | Mouse |
| cellular potassium ion transport | GO:0071804 | 43 | 0.034 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.034 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.034 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.034 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.034 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.034 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.033 | |
| positive regulation of thyroid hormone generation | GO:2000611 | 2 | 0.033 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.033 | |
| pilomotor reflex | GO:0097195 | 3 | 0.033 | |
| ear development | GO:0043583 | 200 | 0.033 | |
| kidney development | GO:0001822 | 213 | 0.033 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.033 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.033 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.032 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.032 | Mouse |
| connective tissue development | GO:0061448 | 179 | 0.032 | |
| renal capsule morphogenesis | GO:0072128 | 1 | 0.032 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.031 | Mouse |
| sulfate assimilation | GO:0000103 | 3 | 0.031 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.031 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.031 | Mouse |
| blood circulation | GO:0008015 | 195 | 0.031 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.031 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.030 | |
| peptide metabolic process | GO:0006518 | 46 | 0.030 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.030 | |
| defense response to other organism | GO:0098542 | 197 | 0.030 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.030 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.030 | Mouse |
| extracellular matrix organization | GO:0030198 | 147 | 0.030 | |
| regulation of urea metabolic process | GO:0034255 | 1 | 0.030 | |
| response to hypoxia | GO:0001666 | 58 | 0.030 | |
| chloride transmembrane transport | GO:1902476 | 24 | 0.030 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.029 | |
| thyroid hormone metabolic process | GO:0042403 | 16 | 0.029 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.029 | |
| regulation of keratinocyte proliferation | GO:0010837 | 15 | 0.029 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.029 | |
| connective tissue replacement involved in inflammatory response wound healing | GO:0002248 | 3 | 0.029 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.029 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.029 | |
| inflammatory response to wounding | GO:0090594 | 4 | 0.028 | |
| negative regulation of fat cell proliferation | GO:0070345 | 2 | 0.028 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.028 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.028 | |
| diacylglycerol metabolic process | GO:0046339 | 6 | 0.028 | |
| macrophage activation | GO:0042116 | 27 | 0.028 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.028 | Mouse |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.028 | |
| glucose homeostasis | GO:0042593 | 128 | 0.027 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.027 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.027 | Mouse |
| cell cell adhesion | GO:0098609 | 41 | 0.027 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.027 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.027 | |
| histone modification | GO:0016570 | 159 | 0.027 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.027 | Mouse |
| organ regeneration | GO:0031100 | 2 | 0.026 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.026 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.026 | |
| brown fat cell proliferation | GO:0070342 | 1 | 0.026 | |
| leukocyte migration | GO:0050900 | 124 | 0.026 | Mouse |
| regulation of transferase activity | GO:0051338 | 263 | 0.026 | |
| gland development | GO:0048732 | 330 | 0.026 | |
| peptide secretion | GO:0002790 | 114 | 0.025 | |
| positive regulation of hormone metabolic process | GO:0032352 | 3 | 0.025 | |
| defense response to bacterium | GO:0042742 | 119 | 0.025 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.025 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.025 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.025 | |
| respiratory tube development | GO:0030323 | 167 | 0.025 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.025 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.025 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.025 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.025 | |
| chromatin organization | GO:0006325 | 206 | 0.025 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.025 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.024 | |
| angiogenesis | GO:0001525 | 201 | 0.024 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.024 | |
| pigment metabolic process | GO:0042440 | 32 | 0.024 | |
| regulation of wound healing | GO:0061041 | 40 | 0.024 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.024 | |
| fat cell differentiation | GO:0045444 | 160 | 0.024 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.024 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.023 | |
| cholesterol transport | GO:0030301 | 38 | 0.023 | |
| response to acid chemical | GO:0001101 | 111 | 0.023 | |
| peptide hormone processing | GO:0016486 | 9 | 0.023 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.022 | |
| sensory perception of sound | GO:0007605 | 97 | 0.022 | |
| tissue remodeling | GO:0048771 | 102 | 0.022 | |
| transition metal ion transport | GO:0000041 | 38 | 0.022 | |
| muscle tissue development | GO:0060537 | 308 | 0.022 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.022 | |
| positive regulation of wound healing | GO:0090303 | 17 | 0.022 | |
| female meiosis chromosome segregation | GO:0016321 | 1 | 0.022 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.022 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.022 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.021 | |
| inorganic anion transmembrane transport | GO:0098661 | 29 | 0.021 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.021 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.021 | |
| positive regulation of growth | GO:0045927 | 104 | 0.021 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.020 | |
| protein autoprocessing | GO:0016540 | 2 | 0.020 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.020 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.020 | |
| detection of glucose | GO:0051594 | 1 | 0.020 | |
| renal capsule specification | GO:0072130 | 1 | 0.020 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.020 | |
| t cell activation | GO:0042110 | 289 | 0.020 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.020 | |
| male gamete generation | GO:0048232 | 285 | 0.020 | |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.020 | |
| rhythmic process | GO:0048511 | 174 | 0.020 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.020 | Mouse |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.020 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.020 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.020 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.020 | |
| chemotaxis | GO:0006935 | 247 | 0.020 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.020 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.019 | |
| polyol metabolic process | GO:0019751 | 26 | 0.019 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.019 | |
| nephron tubule development | GO:0072080 | 84 | 0.019 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.019 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.019 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.019 | Mouse |
| cell recognition | GO:0008037 | 83 | 0.019 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.019 | |
| response to monosaccharide | GO:0034284 | 67 | 0.019 | |
| protein activation cascade | GO:0072376 | 19 | 0.019 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.019 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.019 | |
| sensory perception | GO:0007600 | 245 | 0.019 | Human |
| renal tubule development | GO:0061326 | 87 | 0.019 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.019 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.019 | Mouse |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.019 | |
| spermatogenesis | GO:0007283 | 284 | 0.019 | |
| regulation of cell adhesion mediated by integrin | GO:0033628 | 13 | 0.019 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.018 | |
| regulation of b cell mediated immunity | GO:0002712 | 37 | 0.018 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.018 | |
| body fluid secretion | GO:0007589 | 53 | 0.018 | Mouse |
| skeletal system development | GO:0001501 | 356 | 0.018 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.018 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.018 | |
| entry into host | GO:0044409 | 15 | 0.018 | |
| regulation of glutamate metabolic process | GO:2000211 | 1 | 0.018 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.018 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.018 | |
| digestion | GO:0007586 | 40 | 0.018 | |
| complement activation | GO:0006956 | 16 | 0.018 | |
| response to bile acid | GO:1903412 | 1 | 0.018 | |
| binding of sperm to zona pellucida | GO:0007339 | 34 | 0.018 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.018 | Mouse |
| thyroid hormone generation | GO:0006590 | 7 | 0.017 | |
| hepatocyte growth factor receptor signaling pathway | GO:0048012 | 3 | 0.017 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.017 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.017 | |
| fat cell proliferation | GO:0070341 | 4 | 0.017 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.017 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.017 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.017 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.017 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.017 | |
| granulosa cell differentiation | GO:0060014 | 1 | 0.017 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.017 | |
| c4 dicarboxylate transport | GO:0015740 | 3 | 0.017 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.017 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.017 | |
| protein glycosylation | GO:0006486 | 55 | 0.017 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.017 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.017 | |
| vitamin biosynthetic process | GO:0009110 | 7 | 0.017 | |
| negative regulation of serine type endopeptidase activity | GO:1900004 | 2 | 0.016 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.016 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.016 | |
| negative regulation of transcription from rna polymerase ii promoter by glucose | GO:0000433 | 1 | 0.016 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.016 | |
| response to starvation | GO:0042594 | 65 | 0.016 | |
| calcium ion transport | GO:0006816 | 159 | 0.016 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.016 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.016 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 4 | 0.016 | |
| mesangial cell development | GO:0072143 | 4 | 0.016 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.016 | |
| vasoconstriction | GO:0042310 | 27 | 0.016 | |
| response to stilbenoid | GO:0035634 | 22 | 0.016 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.016 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.016 | Mouse |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.016 | |
| cell fate commitment | GO:0045165 | 210 | 0.016 | |
| negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002823 | 23 | 0.016 | |
| wound healing involved in inflammatory response | GO:0002246 | 4 | 0.016 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.016 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.015 | |
| mitochondrion organization | GO:0007005 | 134 | 0.015 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.015 | |
| positive regulation of transcription from rna polymerase iii promoter | GO:0045945 | 1 | 0.015 | |
| regulation of protein transport | GO:0051223 | 163 | 0.015 | Mouse |
| regulation of transcription by glucose | GO:0046015 | 3 | 0.015 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.015 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.015 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.015 | Mouse |
| regulation of chloride transport | GO:2001225 | 2 | 0.015 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.015 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.015 | |
| adaptive immune response | GO:0002250 | 155 | 0.015 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.015 | |
| renal system development | GO:0072001 | 225 | 0.015 | |
| response to thyroid hormone | GO:0097066 | 2 | 0.015 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.015 | |
| cellular response to peptide | GO:1901653 | 92 | 0.015 | |
| cell adhesion | GO:0007155 | 329 | 0.015 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.014 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.014 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.014 | |
| ossification | GO:0001503 | 216 | 0.014 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.014 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.014 | |
| toxin catabolic process | GO:0009407 | 1 | 0.014 | |
| regulation of t cell mediated immunity | GO:0002709 | 34 | 0.014 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.014 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.014 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.014 | |
| regulation of protein localization | GO:0032880 | 231 | 0.014 | Mouse |
| zymogen activation | GO:0031638 | 41 | 0.014 | |
| mitotic g1 dna damage checkpoint | GO:0031571 | 4 | 0.014 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.014 | |
| gtp catabolic process | GO:0006184 | 143 | 0.014 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.014 | |
| collagen fibril organization | GO:0030199 | 32 | 0.013 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.013 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.013 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.013 | |
| coagulation | GO:0050817 | 78 | 0.013 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.013 | |
| locomotory behavior | GO:0007626 | 195 | 0.013 | |
| negative regulation of epidermis development | GO:0045683 | 9 | 0.013 | |
| keratinocyte migration | GO:0051546 | 3 | 0.013 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.013 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.013 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.013 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.013 | |
| endocrine hormone secretion | GO:0060986 | 15 | 0.013 | |
| natural killer cell activation | GO:0030101 | 44 | 0.013 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.013 | |
| inorganic anion transport | GO:0015698 | 43 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| regulation of calcidiol 1 monooxygenase activity | GO:0060558 | 1 | 0.013 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.013 | |
| innate immune response in mucosa | GO:0002227 | 3 | 0.013 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.013 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.013 | Mouse |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.013 | |
| polyol biosynthetic process | GO:0046173 | 13 | 0.013 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.013 | |
| protein maturation | GO:0051604 | 176 | 0.013 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.013 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.013 | |
| sulfur compound transport | GO:0072348 | 9 | 0.013 | |
| membrane organization | GO:0061024 | 245 | 0.013 | Human |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.013 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.013 | |
| regulation of blood vessel size by renin angiotensin | GO:0002034 | 5 | 0.012 | |
| t cell proliferation | GO:0042098 | 120 | 0.012 | |
| response to drug | GO:0042493 | 75 | 0.012 | |
| cellular response to starvation | GO:0009267 | 57 | 0.012 | |
| regulation of endocrine process | GO:0044060 | 13 | 0.012 | |
| stem cell development | GO:0048864 | 219 | 0.012 | |
| negative regulation of growth | GO:0045926 | 99 | 0.012 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.012 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.012 | |
| regulation of fat cell proliferation | GO:0070344 | 4 | 0.012 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.012 | Mouse |
| sterol transport | GO:0015918 | 38 | 0.012 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.012 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.012 | |
| natural killer cell activation involved in immune response | GO:0002323 | 10 | 0.012 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.012 | |
| l amino acid transport | GO:0015807 | 32 | 0.012 | |
| regulation of serine type endopeptidase activity | GO:1900003 | 2 | 0.012 | |
| dephosphorylation | GO:0016311 | 129 | 0.012 | |
| endocytosis | GO:0006897 | 168 | 0.012 | Mouse |
| cellular response to lipid | GO:0071396 | 145 | 0.012 | Mouse |
| divalent metal ion transport | GO:0070838 | 172 | 0.012 | |
| protein homotrimerization | GO:0070207 | 4 | 0.012 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.012 | Mouse |
| maintenance of location | GO:0051235 | 89 | 0.012 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.012 | |
| protein secretion | GO:0009306 | 111 | 0.012 | Mouse |
| oxidative demethylation | GO:0070989 | 1 | 0.012 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.012 | |
